Treatment of transient hypothyroxinemia of prematurity: A survey of neonatal practice

被引：15

作者：

Golombek S.G. ^{[1
]}

LaGamma E.F. ^{[1
]}

Paneth N. ^{[2
]}

机构：

[1] Department of Pediatrics, Division of Neonatology, Regional Neonatal Center, Westchester Medical Center, New York Medical College, Valhalla, NY

[2] Departments of Epidemiology and Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI

来源：

Journal of Perinatology | 2002年 / 22卷 / 7期

关键词：

D O I：

10.1038/sj.jp.7210791

中图分类号：

学科分类号：

摘要：

We mailed a survey on treatment practices for transient hypothyroxinemia of prematurity (THOP) to 100 randomly selected neonatologist. In the year before the survey, 13 of 62 respondents (21.0%) had treated an averages of 4.5 THOP patients with thyroid hormone hormone, and 3 had treated 10 or more patients. Randomized trials assessing the value of thyroid supplementation in THOP are urgently needed.

引用

页码：563 / 565

页数：2

共 14 条

[1] Reuss M.L., Leviton A., Paneth N., Susser M., Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation, Am. J. Public Health, 87, 10, pp. 1693-1697, (1997)
[2] Reuss M.L., Paneth N., Pinto-Martin J.A., Lorenz J.M., Susser M., The relation of transient hypothyxinemia in preterm infants to neurologic development at two years of age, N. Engl. J. Med, 334, pp. 821-827, (1996)
[3] Den Ouden A.L., Kok J.H., Verkerk P.H., Brand R., Verloove-Vanhorick S.P., The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in national cohort of very preterm and/or very low birthweight infants, Pediatr. Res, 39, pp. 142-145, (1996)
[4] Lucas A., Rennie J., Baker B.A., Morley R., Low plasma triiodothyronine concentrations and outcome in preterm infants, Arch. Dis. Child, 63, pp. 1201-1206, (1988)
[5] Lucas A., Morley R., Fewtrell M.S., Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 years follow up, BMJ, 312, pp. 1132-1133, (1996)
[6] Rapaport R., Rose S.R., Freemark M., Hypothyroxinemia in the preterm infant: The benefits and risk of thyroxine treatment, J. Pediatr, 139, 2, pp. 182-188, (2001)
[7] (1998)
[8] Schonberger W., Grimm W., Emmrich P., Et al., Reduction in mortality rate in premature infants by substitution of thyroid hormones, Eur. J. Pediatr, 135, pp. 245-253, (1981)
[9] Chowdry P., Scanlon J.W., Auerbach R., Abassi V., Result of a controlled double-blind study of thyroid replacement in very-low-birth-weight premature infants with hypothyroxinemia, Pediatrics, 73, pp. 301-305, (1984)
[10] Vanhole C., Aerssens P., Naulaers G., Et al., L-Thyroxine treatment of preterm newborns: Clinical and endocrine effects, Pediatr. Res, 42, pp. 87-92, (1997)

← 1 2 →